Detailed Information
Cited 2 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
MET mutant allele frequency (MAF) is correlated with glesatinib anti-tumor activity in patients with advanced non-small cell lung cancer (NSCLC) harboring MET alterations
- Authors
- Der-Torossian, H[Der-Torossian, H.]; Shapiro, G[Shapiro, G.]; Janne, P[Janne, P.]; Awad, M[Awad, M.]; Reckamp, K[Reckamp, K.]; Miller, W[Miller, W.]; Hong, D[Hong, D.]; Hussein, M[Hussein, M.]; Percent, I[Percent, I.]; Bazenhova, L[Bazenhova, L.]; Dowlati, A[Dowlati, A.]; Dong-Wan, K[Dong-Wan, K.]; Cho, BC[Cho, B. C.]; Park, K[Park, K.]; Tassell, V[Tassell, V.]; Chao, R[Chao, R.]; Faltaos, D[Faltaos, D.]; Christensen, J[Christensen, J.]
- Issue Date
- Nov-2018
- Publisher
- ELSEVIER SCI LTD
- Citation
- EUROPEAN JOURNAL OF CANCER, v.103, pp.E133 - E134
- Indexed
- SCIE
SCOPUS
- Journal Title
- EUROPEAN JOURNAL OF CANCER
- Volume
- 103
- Start Page
- E133
- End Page
- E134
- ISSN
- 0959-8049
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.